142 related articles for article (PubMed ID: 1868246)
1. Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.
Storb R; Sanders JE; Pepe M; Anasetti C; Appelbaum FR; Buckner CD; Deeg HJ; Doney K; Hansen J; Martin P
Blood; 1991 Aug; 78(4):1144-5. PubMed ID: 1868246
[No Abstract] [Full Text] [Related]
2. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.
Storb R; Deeg HJ; Farewell V; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
Blood; 1986 Jul; 68(1):119-25. PubMed ID: 3521761
[TBL] [Abstract][Full Text] [Related]
3. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942
[No Abstract] [Full Text] [Related]
4. What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Storb R; Pepe M; Anasetti C; Appelbaum FR; Beatty P; Doney K; Martin P; Stewart P; Sullivan KM; Witherspoon R
Blood; 1990 Sep; 76(5):1037-45. PubMed ID: 2203481
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
Storb R; Deeg HJ; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Hansen J
Br J Haematol; 1989 Aug; 72(4):567-72. PubMed ID: 2673331
[TBL] [Abstract][Full Text] [Related]
6. Marrow transplant experience for children with severe aplastic anemia.
Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172
[TBL] [Abstract][Full Text] [Related]
7. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
[TBL] [Abstract][Full Text] [Related]
8. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia.
Miyamura K; Kojima S; Takeyama K; Matsushita T; Fukuda M; Horibe K; Minami S; Morishima Y; Matsuyama K; Kodera Y
Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy.
Champlin RE; Ho WG; Nimer SD; Gajewski JG; Selch M; Burnison M; Holley G; Yam P; Petz L; Winston DJ
Transplantation; 1990 Apr; 49(4):720-4. PubMed ID: 2326866
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Storb R; Leisenring W; Deeg HJ; Anasetti C; Appelbaum F; Bensinger W; Buckner CD; Clift R; Doney K; Hansen J
Blood; 1994 May; 83(9):2749-50. PubMed ID: 8167353
[No Abstract] [Full Text] [Related]
11. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
Gluckman E; Horowitz MM; Champlin RE; Hows JM; Bacigalupo A; Biggs JC; Camitta BM; Gale RP; Gordon-Smith EC; Marmont AM
Blood; 1992 Jan; 79(1):269-75. PubMed ID: 1728315
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
Horstmann M; Stockschläder M; Krüger W; Hoffknecht M; Betker R; Kabisch H; Zander A
Ann Hematol; 1995 Aug; 71(2):77-81. PubMed ID: 7654856
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
Locatelli F; Bruno B; Zecca M; Van-Lint MT; McCann S; Arcese W; Dallorso S; Di Bartolomeo P; Fagioli F; Locasciulli A; Lawler M; Bacigalupo A
Blood; 2000 Sep; 96(5):1690-7. PubMed ID: 10961865
[TBL] [Abstract][Full Text] [Related]
14. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
[TBL] [Abstract][Full Text] [Related]
15. Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Sorror ML; Leisenring W; Deeg HJ; Martin PJ; Storb R
Biol Blood Marrow Transplant; 2005 Jul; 11(7):567-8. PubMed ID: 15983557
[No Abstract] [Full Text] [Related]
16. Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease.
Witherspoon RP; Deeg HJ; Lum LG; Ochs HD; Hansen JA; Thomas ED; Storb R
Transplantation; 1984 May; 37(5):456-61. PubMed ID: 6233764
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine as an alternative to cyclophosphamide in the treatment of chronic graft-versus-host disease.
Bunjes D; Heit W; Arnold R; Schmeiser T; Heimpel H
Transplantation; 1986 Feb; 41(2):170-2. PubMed ID: 3511579
[TBL] [Abstract][Full Text] [Related]
18. Marrow graft rejection and veno-occlusive disease of the liver in patients with aplastic anemia conditioned with cyclophosphamide and cyclosporine.
Deeg HJ; Shulman HM; Schmidt E; Yee GC; Thomas ED; Storb R
Transplantation; 1986 Nov; 42(5):497-501. PubMed ID: 3538535
[TBL] [Abstract][Full Text] [Related]
19. Marrow transplantation in aplastic anemia.
Storb R; Buckner CD; Fefer A; Clift RA; Neiman PE; Gluksberg H; Lerner KG; Thomas ED
Transplant Proc; 1974 Dec; 6(4):355-8. PubMed ID: 4612891
[No Abstract] [Full Text] [Related]
20. [Bone marrow transplantation in pediatric patients: review of progress].
Inoue S
Gan To Kagaku Ryoho; 1987 Apr; 14(4):994-1003. PubMed ID: 3551848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
